MIMEDX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates MiMedx Group, Inc. Following Disclosure Of FDA Letter Accusing MiMedx Of Legal Violations

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq. a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”) announces that KSF has commenced an investigation into MiMedx Group, Inc. (Nasdaq: MDXG).

On September 4, 2013, the Food and Drug Administration ("FDA") posted on its website an “Untitled Letter” it sent to MiMedx on August 28, which stated that MiMedx's Surgical Biologics unit violated the Public Health Service Act by unlawfully manufacturing and marketing drugs that are also a biological product without a valid biologics license.

On this news, MiMedx’s shares fell drastically, by over 36%.

KSF’s investigation is focusing on whether MiMedx and/or its officers and directors violated state or federal securities laws.

If you have information that would assist KSF in its investigation, or would like to discuss your legal rights, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis Kahn ( lewis.kahn@ksfcounsel.com) or KSF Partner Melinda Nicholson ( melinda.nicholson@ksfcounsel.com) toll free at 1-877-515-1850.

About Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities class action and shareholder derivative litigation with offices in New York and Louisiana. KSF's lawyers have significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders.

To learn more about KSF, you may visit www.ksfcounsel.com.

Copyright Business Wire 2010

If you liked this article you might like

Finding Bullish and Bearish Stock Reversals

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Merger Buzz Drives Akorn to Top of Health Chart in April

MiMedx Group (MDXG) Weak On High Volume